Compare ATRC & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRC | FPF |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.1B |
| IPO Year | 2005 | N/A |
| Metric | ATRC | FPF |
|---|---|---|
| Price | $41.30 | $18.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $52.22 | N/A |
| AVG Volume (30 Days) | ★ 427.2K | 186.7K |
| Earning Date | 02-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.08% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $518,304,999.00 | N/A |
| Revenue This Year | $16.94 | N/A |
| Revenue Next Year | $12.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 15.80 | N/A |
| 52 Week Low | $28.29 | $13.91 |
| 52 Week High | $43.18 | $18.09 |
| Indicator | ATRC | FPF |
|---|---|---|
| Relative Strength Index (RSI) | 56.44 | 67.74 |
| Support Level | $36.06 | $18.66 |
| Resistance Level | $43.18 | $18.79 |
| Average True Range (ATR) | 1.81 | 0.14 |
| MACD | -0.36 | 0.02 |
| Stochastic Oscillator | 75.63 | 90.91 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.